NCT01064947 - Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Atopic DermatitisSecondary Infection

Interventions

DRUG

Retapamulin 1%

Apply a thin layer of Retapamulin 1% to the affected area twice daily. The treated area may be covered with a sterile bandage or gauze dressing if desired.

Trial Locations (1)

40217

DermResearch, PLLC, Louisville